Answers are grounded in this paper and cite their sources.
Investigates absorption and distribution of dendrobine in rats, suggesting its pharmacological viability.
Dendrobium nobile is a medicinal herb native to China with significant therapeutic properties. Its principal alkaloid derivative, Dendrobine (Den), has a variety of pharmacological activities, although its pharmacokinetics have not been fully elucidated. Here, we established and validated an LC–MS/MS technique and a rat model system to investigate the oral absorption and tissue distribution of Den. The assay demonstrated linearity over the 1–2000 ng/mL concentration range with correlation coefficients exceeding 0.99. Mean recovery values were 84.22%–106.15%, whereas relative standard deviations of matrix effects were 3.02%–10.53%. The precision values both within and between days were below 15%, with accuracies of 88.34% to 113.33%. Following intravenous administration of Den (5 mg/kg), plasma concentrations declined rapidly, yielding an average elimination half‐life of 3.89 h. Oral administration at 40 mg/kg produced a similar rapid decline, with an average half‐life of 3.72 h. Extensive first‐pass metabolism contributed to the low (13%) oral bioavailability of this compound. Den distributed rapidly and broadly to tissues, with the highest accumulation in the liver, and was swiftly eliminated following intraperitoneal administration (40 mg/kg). This LC–MS/MS strategy provides a robust, sensitive, and reproducible platform for quantifying Den in biological matrices, supporting future pharmacokinetic and pharmacodynamic investigations.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: